Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections.
about
Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatricsEight Habits of Highly Effective Antimicrobial Stewardship Programs to Meet the Joint Commission Standards for Hospitals.Clinical outcomes with alternative dosing strategies for piperacillin/tazobactam: a systematic review and meta-analysis.Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us.Adequacy of high-dose cefepime regimen in febrile neutropenic patients with hematological malignanciesPharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearanceCan enteral antibiotics be used to treat pneumonia in the surgical intensive care unit? A clinical outcomes and cost comparison.Bloodstream infections in the Intensive Care Unit.Pharmacokinetics of Peramivir in an Adolescent Patient Receiving Continuous Venovenous Hemodiafiltration.Treatment option for sepsis in children in the era of antibiotic resistance.Optimizing research methods used for the evaluation of antimicrobial stewardship programs.Evaluating outcomes of alternative dosing strategies for cefepime: a qualitative systematic review.Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant enterococci: Three major threats to hematopoietic stem cell transplant recipients.Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance.Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance.The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies.Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.Predicting and preventing antimicrobial resistance utilizing pharmacodynamics: part II Gram-negative bacteria.Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia.Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art.Hospital Length of Stay Among Patients Receiving Intermittent Versus Prolonged Piperacillin/Tazobactam Infusion in the Intensive Care Units.Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa.Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospital.Success With Extended-Infusion Meropenem After Recurrence of Baclofen Pump-Related Achromobacter Xylosoxidans Meningitis in an Adolescent.Implementing extended-infusion cefepime as standard of care in a children's hospital: a prospective descriptive study.Treatment of multidrug-resistant pseudomonas aeruginosa using extended-infusion antimicrobial regimens.Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study.What's new in antimicrobial use and resistance in critically ill patients?Editorial commentary: Are blood concentrations enough for establishing pharmacokinetic/pharmacodynamic relationships?The Role of Cefepime in the Treatment of Extended-Spectrum Beta-Lactamase Infections.An antibiotic stewardship exercise in the ICU: building a treatment algorithm for the management of ventilator-associated pneumonia based on local epidemiology and the 2016 Infectious Diseases Society of America/American Thoracic Society guidelines.Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.Influence of β-Lactam Infusion Strategy on Acute Kidney Injury.Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patientsOptimal infusion rate in antimicrobial therapy explosion of evidence in the last five years
P2860
Q26853629-8781BE52-B709-4FE7-B2BA-480D690FD74FQ30235927-F2264395-7792-46F3-B0CE-F218C68AD038Q34892334-771ADA21-53AF-4B50-9CA6-F34EBD26A978Q35080067-4BF69F37-7390-4B13-AC47-16B490F2ACE4Q35960873-A49111E7-D963-453E-93DD-42359257601BQ36083619-478D23B7-A051-4795-B3DC-395F417EF442Q36089167-C86BDBA5-9706-4663-9EB2-39EA78628DEAQ36184433-3C059F6C-6B0B-439D-9845-29F6A2D16ABBQ36913336-C6C64B46-EF5A-4EC5-864E-2EAF458D4BEEQ37686604-C59E09CA-013E-457D-8CBE-2ED7931EE0C7Q38246118-F996E4CC-30F4-41BC-898C-952BD99D3633Q38254826-3A07B9AD-EF98-4F1D-B794-317B33789E56Q38313276-6AEBBBA9-8D1F-4BDD-8295-74A64FC3BE22Q38620812-9559F4E9-A2A9-4462-BAD9-FDFD65E9CE03Q38672016-8CA8AC87-A9C8-4529-9F97-CA2DC682FB77Q38705266-AD61243B-63C9-4B6F-89A4-A6C7276E425AQ38875315-551454EA-7367-4930-886F-190CEA31A36CQ38896040-8FAE7E21-61F9-4C47-ACC7-E4D69FE88648Q39293585-944DCC3B-A56F-44C1-B045-D758123FBF06Q40073466-D234407A-58AE-4FBD-910F-1E77CA7274EDQ40095692-3E3521BE-DE0C-409F-B59F-56FA7B228C27Q40219976-1A7829AD-C3C7-4DD4-8D23-6136A6CA9686Q40220923-1640C913-55C0-4097-B25E-D0B398846DA4Q40375664-D4955906-F166-4B8B-A72E-E2A471D4D263Q41190839-DA3D92A3-EFFF-4B25-BBF5-0EA8026E0D5FQ41538340-BE4081F1-1DD0-4D74-A641-7F214D095B12Q41564878-A99BDD89-0984-41A3-8764-2D3C025062CCQ42230747-24446310-4471-45FA-911B-ED528FEEA02DQ42236463-933CB136-6F04-4270-A07F-298F7447111AQ44128133-80C0C721-38FD-4F0D-B703-4D78A08E95AFQ47427370-F65FBF7F-19F8-4B2A-8389-055D3C8D6726Q47566277-556896B1-7CC1-428F-9B69-D79BBA92C923Q47661746-2145CD01-8F44-448E-84A5-A798AAC0BCCEQ48707595-FA92C7F7-7CD9-4B1E-A4DA-7DC68F2B9E7BQ58701649-19735B43-138B-419E-9026-D4D7202730AEQ58795590-0838A4A9-3769-4712-BA01-6BF44B4FF66E
P2860
Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Extended-infusion cefepime red ...... domonas aeruginosa infections.
@en
type
label
Extended-infusion cefepime red ...... domonas aeruginosa infections.
@en
prefLabel
Extended-infusion cefepime red ...... domonas aeruginosa infections.
@en
P2093
P2860
P356
P1476
Extended-infusion cefepime red ...... domonas aeruginosa infections.
@en
P2093
Debra A Goff
James M O'Brien
Jessica E West
Karri A Bauer
P2860
P304
P356
10.1128/AAC.02365-12
P407
P577
2013-04-09T00:00:00Z